✦ LIBER ✦

Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease

✍ Scribed by Soumerai, Jacob D.; Hellmann, Matthew D.; Feng, Yang; Sohani, Aliyah R.; Toomey, Christiana E.; Barnes, Jeffrey A.; Takvorian, Ronald W.; Neuberg, Donna; Hochberg, Ephraim P.; Abramson, Jeremy S.

Book ID: 124151910
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 403 KB
Volume: 55
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.810738

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epratuzumab with rituximab, cyclophospha

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

✍ Micallef, I. N. M.; Maurer, M. J.; Wiseman, G. A.; Nikcevich, D. A.; Kurtin, P. 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 193 KB

Successful Treatment of Diffuse Large B-

Successful Treatment of Diffuse Large B-Cell Non-Hodgkin Lymphoma with Modified CHOP (Cyclophosphamide/Doxorubicin/Vincristine/ Prednisone) Chemotherapy and Rituximab in a Patient with Nijmegen Syndrome

✍ Dumic, Miroslav; Radman, Ivo; Krnic, Nevena; Nola, Marin; Kusec, Rajko; Begovic, 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 885 KB

A pilot study of epratuzumab and rituxim

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

✍ Ivana N. M. Micallef; Brad S. Kahl; Matthew J. Maurer; Ahmet Dogan; Stephen M. A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

A phase 1 dose escalation study of borte

A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas

✍ Rajni Sinha; Jonathan L. Kaufman; Hanna Jean Khoury Jr.; Nassoma King; Pareen J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 839 KB

Cyclophosphamide, doxorubicin, vincristi

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi

✍ Merli, Francesco; Luminari, Stefano; Rossi, Giuseppe; Mammi, Caterina; Marchesel 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 422 KB